Supplementary Figure 4 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Abstract
Validation of the tumor-targeting capacity and low toxicity of circCDUPRT on a 4T1 tumor-bearing mouse model.
Fields of Study & Subjects
Circular RNAs in diseases
Cancer Research and Treatments
RNA Interference and Gene Delivery
Publication details
- Publication date
- 4 February 2026